Editorial
doi: 10.1097/01.ju.0000118140.73627.ed.
Biopsy of the prostate--an ongoing evolution
- PMID: 15017204
- DOI: 10.1097/01.ju.0000118140.73627.ed
Item in Clipboard
Editorial
Biopsy of the prostate--an ongoing evolution
J Urol.
2004 Apr.
No abstract available
Comment on
-
Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores.J Urol. 2004 Apr;171(4):1478-80; discussion 1480-1. doi: 10.1097/01.ju.0000116449.01186.f7. J Urol. 2004. PMID: 15017202
-
The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable.J Urol. 2004 Apr;171(4):1500-3. doi: 10.1097/01.ju.0000118052.59597.83. J Urol. 2004. PMID: 15017207 Clinical Trial.
Similar articles
-
Biopsy diagnosis of prostatic cancer--current areas of concern.J Clin Pathol. 1997 Apr;50(4):265-6. doi: 10.1136/jcp.50.4.265. J Clin Pathol. 1997. PMID: 9215135 Free PMC article. No abstract available.
-
Editorial comment on: reassessing the diagnostic yield of saturation biopsy of the prostate.Eur Urol. 2008 May;53(5):981-2. doi: 10.1016/j.eururo.2007.10.050. Epub 2007 Nov 5. Eur Urol. 2008. PMID: 17997013 No abstract available.
-
Editorial comment on: reassessing the diagnostic yield of saturation biopsy of the prostate.Eur Urol. 2008 May;53(5):982-3. doi: 10.1016/j.eururo.2007.10.051. Epub 2007 Nov 5. Eur Urol. 2008. PMID: 17997023 No abstract available.
-
Management of rising prostate-specific antigen following a negative biopsy.Curr Opin Urol. 2010 May;20(3):198-203. doi: 10.1097/mou.0b013e3283385fbd. Curr Opin Urol. 2010. PMID: 20583345 Review. No abstract available.
-
Defining prostate cancer risk before prostate biopsy.Urol Oncol. 2013 Nov;31(8):1408-18. doi: 10.1016/j.urolonc.2012.05.012. Epub 2012 Jul 12. Urol Oncol. 2013. PMID: 22795499 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical